Sagent Pharmaceuticals Inc is recalling approximately 4,870,160 units of Nafcillin for Injection, USP (generic nafcillin), distributed in 1 gram vials, 2 gram vials, and 10 gram pharmacy bulk packages. This recall was initiated because the manufacturer cannot guarantee the sterility of these medications. Using a non-sterile injectable drug can lead to serious, life-threatening infections such as bacteremia or sepsis. These prescription antibiotics were manufactured in the United States and distributed nationwide to healthcare facilities.
A lack of sterility assurance means the medication may contain bacteria or fungi. When injected directly into the bloodstream or tissue, these contaminants can cause severe systemic infections, which are particularly dangerous for hospitalized patients with weakened immune systems.
Rx only; Mfd. for SAGENT Pharmaceuticals, Schaumburg, IL 60195.
Rx only; Mfd. for SAGENT Pharmaceuticals, Schaumburg, IL 60195.
Rx only; Mfd. for SAGENT Pharmaceuticals, Schaumburg, IL 60195.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.